SYK Inhibitors, Entospletinib and Lanraplenib, Show Potent Anti-Leukemic Activity in Combination with Targeted Agents
| Autor: | Carvajal, Luis A. *, McKeown, Michael *, Hood, Tressa *, Kumar, Pavan *, Saffran, Douglas C. *, DiMartino, Jorge |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:5932-5933 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|